Cells, Proteins, and Biomaterials in Translational Medicine

Immunoengineering integrates principles from engineering and the physical sciences with immunology to develop transformative solutions for human health. Breakthroughs in engineered immune cells (e.g., CAR-T cells), antibodies, nucleic acid-based therapies, biomaterials and nanotechnology have revolutionized treatments for cancer, infectious diseases, and autoimmune disorders. The field continues to expand, with novel vaccine platforms and immune-modulating technologies pushing the boundaries of medicine. At the same time, emerging tools are providing deeper insights into the immune mechanisms underlying disease and revealing new strategies to restore normal immune function. Building on the success of previous meetings, the 2026 conference will provide a collaborative space to discuss molecular, cellular, and tissue-scale advances, translational applications, and emerging trends in immunoengineering to advance medicine. We invite researchers at all career stages to apply and contribute to shaping the future of this dynamic field. Join us for an immersive experience that sparks new ideas, builds connections, and propels immunoengineering forward.